发明名称 |
ANTIBODIES AGAINST AMYLOID-BETA PEPTIDE |
摘要 |
Antibodies that bind human β-amyloid peptide, methods of treating diseases or disorders characterised by elevated β-amyloid levels or β-amyloid deposits with said antibodies, pharmaceutical compositions comprising said antibodies and methods of manufacture. |
申请公布号 |
US2016024197(A1) |
申请公布日期 |
2016.01.28 |
申请号 |
US201514881428 |
申请日期 |
2015.10.13 |
申请人 |
GLAXO GROUP LIMITED |
发明人 |
BURBIDGE Stephen Anthony;Kumar Umesh;Philpott Karen Louise;Soden Peter Ernest;Ellis Jonathan Henry;Ford Susannah K;Germaschewski Volker |
分类号 |
C07K16/18 |
主分类号 |
C07K16/18 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating Alzheimer's disease in a human patient comprising administering to the patient an effective amount of an isolated antibody or antigen binding fragment thereof which binds β-amyloid peptide and which comprises the following CDRs:CDRH1:(SEQ ID No: 1)DNGMACDRH2:(SEQ ID No: 2)FISNLAYSIDYADTVTGCDRH3:(SEQ ID No: 3)GTWFAY within a human heavy chain variable region originating from the VH3 gene family and:CDRL1:(SEQ ID No: 4)RVSQSLLHSNGYTYLHCDRL2:(SEQ ID No: 5)KVSNRFSCDRL3:(SEQ ID No: 6)SQTRHVPYT within a human light chain variable region originating from the amino acid sequence disclosed in GenPept entry CAA51135 (SEQ ID No:24). |
地址 |
Brentford GB |